Lonza primary immune cells and media

Friday, 11 June, 2010 | Supplied by: Capsugel Australia Pty Ltd

Lonza supplies a variety of primary cells isolated from normal peripheral blood, cord blood and bone marrow along with media specifically developed for culturing primary immune cells.

Cells are available to fit specific experimental needs, with a large selection of donors and lots and multiple immune cell types are available from the same donor.

Cells are processed to ensure highly homogeneous populations with high purity (≥85%) and viabilities of 100% of the stated cell number per product label.

Primary cells include: CD41+ monocytes, CD4+ T-cells, CD19+ B-cells, dendritic cells, NK cells, mononuclear cells.

LGM-3 Lymphocyte Growth Medium-3 was developed for the growth and support of human lymphocytes and dendritic cells.

Online: www.capsugel.com
Phone: 1300 657508
Related Products

Cayman Chemical Cell Death Screening Library

Cayman Chemical's Cell Death Screening Library consists of two plates and contains...

GeneTex circadian rhythm antibodies

Circadian rhythms are physical, behavioural and mental changes that respond primarily to the...

Enzo Life Sciences SCREEN-WELL Cardiotoxicity Library

The SCREEN-WELL Cardiotoxicity Library from Enzo Life Sciences is a focused collection of 130...

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd